Despite failed attempts to acquire foreign pharma companies, three Indian pharma majors Ranbaxy, Wockhardt and Nicholas Piramal are now looking at acquiring Germany’s fourth largest generic firm, betapharm Arzneimittel GmbH.
Despite failed attempts to acquire foreign pharma companies, three Indian pharma majors Ranbaxy, Wockhardt and Nicholas Piramal are now looking at acquiring Germany’s fourth largest generic firm, betapharm Arzneimittel GmbH.
